Beam Therapeutics Inc. - COMMON STOCK (BEAM) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
BEAM on Nasdaq
Shares outstanding
100,548,635
Price per share
$30.97
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
106,797,303
Total reported value
$2,960,904,700
% of total 13F portfolios
0%
Share change
+221,456
Value change
+$15,891,836
Number of holders
241
Price from insider filings
$30.97
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Beam Therapeutics Inc. - COMMON STOCK (BEAM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 13% -7.1% $353,440,240 -$28,167,623 12,750,369 -7.4% FMR LLC 31 Dec 2025
ARK Investment Management LLC 12% +19% $345,590,479 +$57,021,481 12,467,189 +20% ARK Investment Management LLC 31 Dec 2025
Farallon Capital Partners, L.P. 10% 0% $281,132,248 +$4,681,243 10,141,856 +1.7% Dapice Joshua J. 31 Dec 2025
BlackRock, Inc. 7.5% $147,823,620 7,499,930 BlackRock, Inc. 31 Mar 2025
STATE STREET CORP 5.2% $144,934,824 5,228,529 STATE STREET CORPORATION 31 Dec 2025
ARCH Venture Fund IX, L.P. 4.6% -17% $90,680,723 4,600,747 0% Robert Nelsen 31 Mar 2025

As of 31 Dec 2025, 241 institutional investors reported holding 106,797,303 shares of Beam Therapeutics Inc. - COMMON STOCK (BEAM). This represents 106% of the company’s total 100,548,635 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) together control 93% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARK Investment Management LLC 12% 12,467,189 +13% 2.3% $345,590,488
FMR LLC 12% 11,909,138 +1.8% 0.02% $330,121,317
FARALLON CAPITAL MANAGEMENT LLC 10% 10,063,111 0% 1.6% $278,949,437
VANGUARD GROUP INC 9.1% 9,193,474 -0.62% 0% $254,843,099
BlackRock, Inc. 8.4% 8,450,182 +3.7% 0% $234,239,046
STATE STREET CORP 5.2% 5,228,529 +30% 0% $144,934,824
ARCH Venture Management, LLC 4.5% 4,540,132 0% 19% $125,852,459
Sumitomo Mitsui Trust Group, Inc. 4.4% 4,409,300 -8.7% 0.07% $122,225,796
Amova Asset Management Americas, Inc. 4.4% 4,409,300 -8.7% 1.4% $122,181,703
PRICE T ROWE ASSOCIATES INC /MD/ 2.7% 2,730,282 +21% 0.01% $75,684,000
Kynam Capital Management, LP 2.4% 2,440,214 -3.1% 4.4% $67,642,732
GEODE CAPITAL MANAGEMENT, LLC 2.3% 2,351,908 -1.6% 0% $65,206,279
DIMENSIONAL FUND ADVISORS LP 1.9% 1,947,879 +13% 0.01% $53,995,738
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1.7% 1,712,359 +2.8% 0.01% $47,466,591
Casdin Capital, LLC 1.6% 1,600,000 0% 2.8% $44,352,000
Redmile Group, LLC 1.3% 1,285,859 -7.3% 2.6% $35,644,011
MWG Caph Ltd 1.3% 1,266,934 0% 49% $35,119,410
TWO SIGMA INVESTMENTS, LP 1.1% 1,120,389 +196% 0.05% $31,057,183
Woodline Partners LP 0.99% 993,066 +82% 0.11% $27,527,790
UBS Group AG 0.97% 973,843 -14% 0.01% $26,994,928
MARSHALL WACE, LLP 0.94% 945,829 0.03% $26,218,379
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.83% 834,795 -0.76% 0% $23,140,517
NORTHERN TRUST CORP 0.8% 808,947 -5.3% 0% $22,424,012
MORGAN STANLEY 0.73% 729,400 +13% 0% $20,218,979
JPMORGAN CHASE & CO 0.62% 619,241 +14% 0% $17,165,361

Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 106,797,303 $2,960,904,700 +$15,891,836 $27.72 241
2025 Q3 106,531,653 $2,585,329,209 -$9,441,913 $24.27 214
2025 Q2 108,325,993 $1,842,599,951 +$102,159,924 $17.01 213
2025 Q1 101,329,623 $1,984,124,636 +$387,248,348 $19.53 234
2024 Q4 81,429,029 $2,019,888,804 +$52,922,730 $24.80 228
2024 Q3 78,929,001 $1,933,839,851 +$32,128,779 $24.50 217
2024 Q2 77,540,507 $1,816,892,862 +$138,460,483 $23.43 210
2024 Q1 70,332,894 $2,323,064,829 +$51,308,447 $33.04 217
2023 Q4 68,925,790 $1,876,215,663 +$46,457,918 $27.22 183
2023 Q3 67,439,160 $1,621,864,483 +$72,305,572 $24.05 190
2023 Q2 64,198,552 $2,049,551,170 +$123,991,732 $31.93 191
2023 Q1 60,372,846 $1,848,161,788 +$134,989,244 $30.62 205
2022 Q4 55,910,182 $2,186,652,051 +$42,258,811 $39.11 205
2022 Q3 54,633,598 $2,601,918,929 -$6,231,369 $47.64 214
2022 Q2 54,764,598 $2,088,902,541 +$192,782,034 $38.71 191
2022 Q1 49,225,196 $2,820,671,022 +$201,996,007 $57.30 230
2021 Q4 45,547,893 $3,629,719,477 -$39,454,291 $79.69 224
2021 Q3 45,176,306 $3,933,867,577 -$43,842,015 $87.01 223
2021 Q2 45,484,033 $5,854,372,685 +$342,578,385 $128.71 223
2021 Q1 43,012,900 $3,436,702,468 +$478,571,473 $80.04 203
2020 Q4 36,917,618 $3,014,269,128 +$632,622,766 $81.64 152
2020 Q3 29,525,955 $726,945,347 +$39,624,702 $24.62 84
2020 Q2 27,707,853 $775,554,484 +$34,103,632 $28.00 70
2020 Q1 26,888,544 $483,990,454 +$483,990,450 $18.00 60